Dr. Nicholas Agresti, whose patients received lero
Post# of 148279
(Total Views: 741)
Posted On: 09/10/2020 6:31:41 PM
Dr. Nicholas Agresti, whose patients received leronlimab under the U.S. Food and Drug Administration (FDA) emergency IND (eIND) program. Dr. Dhody will discuss the very successful FDA meeting concerning CytoDyn’s upcoming HIV BLA submission and Dr. Agresti will speak about the experience of his patients who received leronlimab.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼